{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:39:01Z","timestamp":1761323941162,"version":"build-2065373602"},"reference-count":18,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T00:00:00Z","timestamp":1398643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Previous studies have shown that the association of the drug meglumine antimoniate (MA) with \u03b2-cyclodextrin can improve its bioavailability by the oral route. In this work, ribose and maltose were investigated for their ability to form mixed or association complexes with MA, release MA and modulate the serum levels of Sb after oral administration in mice. Analysis of the MA\/ribose composition by high performance liquid chromatography coupled to mass spectrometry (LCMS-IT-TOF) revealed the presence of mixed meglumine-Sb-ribose and Sb-ribose complexes. Analysis of the MA\/maltose composition suggested the formation of MA-maltose association compounds. Circular dichroism characterization of these compositions following dilution in water at  37 \u00b0C suggested a partial and slow dissociation of the association compounds. When the MA\/ribose composition was administered orally and compared to MA, the serum concentration of Sb was significantly lower after 1 h and greater after 3 h. On the other hand, the MA\/maltose composition showed similar serum Sb concentration after 1 h and higher level of Sb after 3 h, when compared to MA. In conclusion, the present study has demonstrated the formation of mixed or association complexes of MA with sugars, such as maltose and ribose, which promoted sustained serum level of Sb after oral administration.<\/jats:p>","DOI":"10.3390\/molecules19055478","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T11:40:09Z","timestamp":1398685209000},"page":"5478-5489","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Mixed Antimony(V) Complexes with Different Sugars to Modulate the Oral Bioavailability of Pentavalent  Antimonial Drugs"],"prefix":"10.3390","volume":"19","author":[{"given":"Weverson","family":"Ferreira","sequence":"first","affiliation":[{"name":"Department of Chemistry, Institute of Exact Sciences \u2013 Federal University of Minas Gerais (UFMG), Av. Ant\u00f4nio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshad","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Institute of Exact Sciences \u2013 Federal University of Minas Gerais (UFMG), Av. Ant\u00f4nio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aretha","family":"Andrade","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Institute of Exact Sciences \u2013 Federal University of Minas Gerais (UFMG), Av. Ant\u00f4nio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flaviana","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, Institute of Biological Sciences \u2013 Federal University of Minas Gerais (UFMG), Av. Ant\u00f4nio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Fr\u00e9zard","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, Institute of Biological Sciences \u2013 Federal University of Minas Gerais (UFMG), Av. Ant\u00f4nio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Demicheli","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Institute of Exact Sciences \u2013 Federal University of Minas Gerais (UFMG), Av. Ant\u00f4nio Carlos 6627, Belo Horizonte 31270-901, MG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2014,4,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1128\/AAC.00639-13","article-title":"Amphiphilic antimony(V) complexes for oral treatment of visceral leishmaniasis","volume":"57","author":"Fernandes","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2006.06.014","article-title":"Mode of action of \u03b2-cyclodextrin as an absorption enhancer of the water-soluble drug meglumine antimoniate","volume":"325","author":"Martins","year":"2006","journal-title":"Int. J. Pharm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jinorgbio.2007.10.010","article-title":"New insights into the chemical structure and composition of the pentavalent antimonial drugs meglumine antimonate and sodium stibogluconate","volume":"102","author":"Frezard","year":"2008","journal-title":"J. Inorg. Biochem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/AAC.48.1.100-103.2004","article-title":"Oral delivery of meglumine antimoniate-beta-cyclodextrin complex for treatment of leishmaniasis","volume":"48","author":"Demicheli","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpharm.2007.06.029","article-title":"Enhanced oral delivery of antimony from meglumine antimoniate\/\u03b2-cyclodextrin nanoassemblies","volume":"347","author":"Martins","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/bdd.695","article-title":"Prolonged absorption of antimony(V) by the oral route from non-i nclusion meglumine antimoniate-beta-cyclodextrin conjugates","volume":"31","author":"Ribeiro","year":"2010","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1517\/17425247.2010.529897","article-title":"New delivery strategies for the old pentavalent antimonial drugs","volume":"7","author":"Demicheli","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0304-4165(02)00198-8","article-title":"Antimony(V) complex formation with adenine nucleosides in aqueous solution","volume":"1570","author":"Demicheli","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ica.2005.09.003","article-title":"Synthesis and characterization of Sb(V)\u2013adenosine and Sb(V)\u2013guanosine complexes in aqueous solution","volume":"359","author":"Demicheli","year":"2006","journal-title":"Inorg. Chim. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10534-006-0001-4","article-title":"Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH","volume":"19","author":"Ferreira","year":"2006","journal-title":"Biometals"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: New perspectives for old drugs","volume":"14","author":"Demicheli","year":"2009","journal-title":"Molecules"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00216-006-0456-8","article-title":"Mass spectrometric identification and characterization of antimony complexes with ribose-containing biomolecules","volume":"385","author":"Hansen","year":"2006","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/aoc.425","article-title":"Pentavalent organoantimonial derivatives: Two simple and efficient synthetic methods for meglumine antimonate","volume":"17","author":"Demicheli","year":"2003","journal-title":"Appl. Organomet. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1009200330741","article-title":"Physico-chemical characterization of meglumine antimoniate","volume":"12","author":"Demicheli","year":"1999","journal-title":"BioMetals"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/19\/5\/5478\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:10:47Z","timestamp":1760217047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/19\/5\/5478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,28]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5]]}},"alternative-id":["molecules19055478"],"URL":"https:\/\/doi.org\/10.3390\/molecules19055478","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2014,4,28]]}}}